United States Antimony Corporation (UAMY) focuses on mining and processing antimony, a critical mineral essential for flame retardants, batteries, and military applications. The company operates through its Antimony and Zeolite segments, producing antimony oxides, metals, and zeolite products for various industrial uses. From its headquarters in Montana, UAMY smelts antimony ore at facilities in Thompson Falls and holds mining claims across the U.S., Canada, and Mexico.
In my view, UAMY's vertically integrated business model—from mining to refining—positions it well as a domestic supplier, especially with global supply disruptions, particularly from China. This exposure to critical minerals has driven much of the recent stock movement, as geopolitical tensions and U.S. policy shifts emphasize onshore production. While competitors like Perpetua Resources are larger, UAMY's government contracts and cost-effective expansions carve out a niche in antimony trisulfide for defense applications. I also checked this using Tickeron’s AI Screener to see how the stock stacks up against others in the industry.
Looking at the past 30 days, UAMY stock climbed +15%, moving from a close near $9.29 around mid-April to $10.65 more recently. The advance was volatile and trend-driven, featuring sharp rallies from April 30 to May 6 that pushed highs to $12.61, followed by pullbacks on profit-taking. Volumes were notably high, topping 17 million shares on peak days, which highlighted the momentum.
Over the past quarter, shares rose +32%, starting from $8.09 in early February. The performance showed steady uptrends with interruptions like post-earnings dips in March, but it stayed range-bound between $7 and $13 before breaking higher. From what I see, this mirrors broader strength in the critical minerals sector.
The +15% gain in the last 30 days came from growing attention to UAMY's role in U.S. critical minerals supply chains. A major catalyst was spillover sentiment from rare earths and tungsten updates, including the Fostung project technical report that confirmed significant inferred resources. This shifted valuation views, with shares jumping 24.7% in a single session.
Other factors included the $106.7 million antimony trioxide supply deal and strong demand for antimony, which fueled buying despite an 11.3% dip from profit-taking. Executive news, like appointing Shawn Winkler as interim CFO, added volatility but pointed to operational stability. Sector tailwinds from rising antimony prices—due to export restrictions—amplified the gains amid elevated volumes.
The quarterly +32% advance rested on ongoing developments from fiscal 2025 results, which delivered 163% revenue growth to $39.3 million and a 185% increase in gross profit, thanks to higher antimony prices and volumes. The $248 million sole-source contract with the Defense Logistics Agency for antimony ingots over five years solidified UAMY's strategic importance.
Acquisitions such as the Fostung tungsten property—holding 14.77 million tonnes inferred at 0.17% WO3—and restarts at the Stibnite Hill mine strengthened the resource base. Broader U.S. efforts to secure domestic critical minerals amid China restrictions lifted sentiment. Institutional interest and smelter expansions added upward pressure, even with some earnings-related dips.
In my research and trading, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots from hundreds available. These bots analyze and trade thousands of tickers across markets using strategies like trend-following, mean reversion, and momentum, from intraday to long-term plays. Metrics such as win rate, profit factor, and Sharpe ratio make it straightforward to pick bots matching my risk tolerance and approach. Updated in real-time, the list spotlights those thriving in current conditions, helping me add automation to my analysis.
One thing that stands out for investors is the Q1 2026 earnings on May 14, including webcast details on antimony deliveries and smelter progress. Keep an eye on execution of the $248 million DLA contract and the $75 million in projected 2026 antimony sales. Trends in critical minerals pricing for antimony and tungsten, amid supply constraints, will be crucial.
I'm watching macro influences like U.S. defense spending, inflation, and import regulations closely. Strategic initiatives—such as ramps in Montana and Alaska mining, Fostung development, and hydrometallurgical joint ventures—could spark further moves. That said, risks like execution delays, commodity swings, and funding needs persist, even with a $91 million cash position. This is important because it underscores the balance between opportunity and volatility in this space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
UAMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where UAMY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UAMY's RSI Oscillator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where UAMY advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on June 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UAMY as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for UAMY turned negative on June 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .
UAMY moved below its 50-day moving average on June 03, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for UAMY crossed bearishly below the 50-day moving average on May 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UAMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for UAMY entered a downward trend on June 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UAMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UAMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.403) is normal, around the industry mean (12.498). P/E Ratio (0.000) is within average values for comparable stocks, (126.804). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.451). UAMY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.022). P/S Ratio (25.000) is also within normal values, averaging (341.756).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a producer of antimony products
Industry OtherMetalsMinerals